Unlock stock picks and a broker-level newsfeed that powers Wall Street.

April 2025's Top Growth Stocks With Strong Insider Ownership

In This Article:

Over the last 7 days, the United States market has experienced a 4.4% decline, maintaining a flat performance over the past year with earnings forecasted to grow by 13% annually. In such conditions, stocks that exhibit strong growth potential coupled with high insider ownership can be particularly appealing as they often indicate confidence from those closest to the company in its future prospects.

Top 10 Growth Companies With High Insider Ownership In The United States

Name

Insider Ownership

Earnings Growth

Super Micro Computer (NasdaqGS:SMCI)

14.2%

29.8%

Hims & Hers Health (NYSE:HIMS)

13.2%

21.8%

Duolingo (NasdaqGS:DUOL)

14.4%

37.2%

Credo Technology Group Holding (NasdaqGS:CRDO)

12.2%

65.1%

Astera Labs (NasdaqGS:ALAB)

15.8%

61.4%

Niu Technologies (NasdaqGM:NIU)

36%

82.8%

Red Cat Holdings (NasdaqCM:RCAT)

18.3%

123%

Clene (NasdaqCM:CLNN)

19.4%

63.1%

Upstart Holdings (NasdaqGS:UPST)

12.6%

100.2%

Credit Acceptance (NasdaqGS:CACC)

14.4%

33.8%

Click here to see the full list of 201 stocks from our Fast Growing US Companies With High Insider Ownership screener.

Let's review some notable picks from our screened stocks.

AlTi Global

Simply Wall St Growth Rating: ★★★★☆☆

Overview: AlTi Global, Inc. offers wealth and asset management services across the United States, the United Kingdom, and internationally with a market cap of approximately $463.70 million.

Operations: The company's revenue segments include Corporate at $0.14 million, International Real Estate at $8.54 million, and Wealth & Capital Solutions at $198.26 million.

Insider Ownership: 37.7%

AlTi Global is experiencing financial challenges, with a net loss of US$98.14 million for 2024, though losses have narrowed from the previous year. Revenue forecasts suggest growth at 14.8% annually, surpassing the US market average but below high-growth thresholds. The company anticipates profitability in three years, indicating above-average market growth potential. Recent leadership changes include appointing Mike Harrington as CFO to strengthen financial strategy amid limited cash runway and past shareholder dilution concerns.

NasdaqCM:ALTI Ownership Breakdown as at Apr 2025
NasdaqCM:ALTI Ownership Breakdown as at Apr 2025

Bausch Health Companies

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Bausch Health Companies Inc. is a diversified specialty pharmaceutical and medical device company that develops, manufactures, and markets products in areas such as gastroenterology, neurology, dermatology, and eye health globally, with a market cap of approximately $1.88 billion.